FATRO acquires majority stake in Güneşli Aşı

Strengthening biological manufacturing and vaccine production across strategic Eurasian animal health corridors.

FATRO S.p.A. has formally concluded an agreement to acquire a majority shareholding in Güneşli Aşı, expanding its vaccine development infrastructure and presence in dynamic livestock markets across the Mediterranean and Central Asian regions. The strategic union enhances research into biological prophylactics for ruminants and poultry.